On February 8, 2021, the Ministry of Health of the Republic of Azerbaijan has allowed the conduct of clinical studies in the Republic of Azerbaijan for the joint use of the vaccine "Sputnik V" and the vaccine developed by AstraZeneca jointly with Oxford University. These studies are expected to begin by the end of February this year, the Ministry of Health told APA.
Earlier, N.F. Gamaleya Scientific Research Institute, Russian Direct Investment Fund (RDIF), AstraZeneca, and R-Pharm Group of Companies signed a memorandum of cooperation with the participation of Russian President Vladimir Putin in the field of coronavirus vaccine development in December 2020.
The first joint applies of vaccines in the world is carried out within the framework of the protocol of clinical trial registered on December 24, 2020.
Tətbiqimizi yükləyə bilərsiniz
